However, in contrast to previous reports [13,19], the circulating levels of sP-selectin, PF-4/CXCL4, or RANTES/CCL5 did not differ between the groups that were investigated here, which suggests a moderate thrombogenic profile in the metabolic syndrome patients. This evidence concerns the gene PF4 and metabolic syndrome.